Curanex Pharmaceuticals, Inc. engages in the pharmaceutical business. It focuses on developing and commercializing botanical treatments for inflammatory diseases. The company was founded by Ying Jing and Chang Liu in 1996 and is headquartered in Jericho, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Curanex Pharmaceuticals Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Curanex Pharmaceuticals Inc. market cap is $22.65M.
What is the 52-week high for Curanex Pharmaceuticals Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Curanex Pharmaceuticals Inc. 52 week high is $9.18 as of October 04, 2025.
What is the 52-week low for Curanex Pharmaceuticals Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Curanex Pharmaceuticals Inc. 52 week low is $0.662 as of October 04, 2025.
What is Curanex Pharmaceuticals Inc. stock price today?
Curanex Pharmaceuticals Inc. stock price today is $0.78.
What was Curanex Pharmaceuticals Inc. stock price yesterday?
Curanex Pharmaceuticals Inc. stock price yesterday was $0.80.
What is the PE ratio of Curanex Pharmaceuticals Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Curanex Pharmaceuticals Inc.’s P/E ratio is -50.96.
What is the Price-to-Book ratio of Curanex Pharmaceuticals Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Curanex Pharmaceuticals Inc. P/B ratio is 72.7273.
What is the 50-day moving average of Curanex Pharmaceuticals Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Curanex Pharmaceuticals Inc. 50-day moving average is $4.24.
